高级检索

2020—2024年河北省麻疹和风疹疑似病例血清学分析:基于常规监测数据

Serological test results of suspected measles and rubella cases in Hebei province from 2020 to 2024: a study based on routine surveillance data

  • 摘要:
    目的 了解2020—2024年河北省麻疹和风疹疑似病例免疫球蛋白M(IgM)抗体检测状况及其流行病学特征,为推动麻疹和风疹防控工作的有效开展提供关键技术支撑。
    方法 采用酶联免疫吸附试验(ELISA)对2020年1月1日—2024年12月31日采集的河北省疑似麻疹和风疹病例血清样本进行IgM抗体检测及结果分析。
    结果 2020—2024年河北省共检测麻疹和风疹疑似病例血清样本8064份,其中麻疹IgM抗体阳性214份,阳性率为2.65%;风疹IgM抗体阳性80份,阳性率为0.99%。2020、2021、2022、2023、2024年麻疹和风疹IgM抗体阳性率分别为5.38%和2.30%、2.70%和0.97%、2.05%和0.85%、1.89%和0.54%、1.58%和0.47%,2020—2024年河北省麻疹和风疹疑似病例IgM抗体阳性率均呈下降趋势(均P<0.001)。2020—2024年河北省麻疹和风疹疑似病例中每月均有麻疹和风疹阳性病例检出,均以1月份检出的IgM抗体阳性率为最高,分别为18.67%和12.03%。2020—2024年河北省各市麻疹和风疹疑似病例中均有麻疹和风疹阳性病例检出,麻疹和风疹IgM抗体阳性率最高的地区分别为沧州市(4.73%)和秦皇岛市(4.21%)。男性和女性麻疹疑似病例IgM抗体阳性率分别为2.75%和2.54%;风疹疑似病例IgM抗体阳性率分别为1.11%和0.86%;不同性别麻疹和风疹IgM抗体阳性率差异均无统计学意义(均P>0.05);年龄<8个月、8个月~4岁、5~9岁、10~19岁和≥20岁麻疹疑似病例IgM抗体阳性率分别为3.77%、3.95%、1.45%、1.99%和1.40%;风疹疑似病例IgM抗体阳性率分别为0.94%、0.70%、0.65%、4.47%和0.75%;不同年龄麻疹和风疹IgM抗体阳性率差异均有统计学意义(均P<0.001);无免疫史、有1剂次免疫史和有2剂次免疫史麻疹疑似病例IgM抗体阳性率分别为2.80%、8.46%和0.79%;风疹疑似病例IgM抗体阳性率分别为1.16%、1.34%和0.76%;不同免疫史麻疹IgM抗体阳性率差异有统计学意义(χ2=209.186,P<0.001),风疹IgM抗体阳性率差异无统计学意义(P>0.05)。
    结论 2020—2024年河北省麻疹和风疹疑似病例IgM抗体阳性率呈下降趋势,1月份阳性率最高,沧州市和秦皇岛市分别为麻疹和风疹的重点防控地区,麻疹预防主要以小年龄组和未完成全程接种人群为主,风疹预防主要以10⁓19岁年龄组人群为主。

     

    Abstract:
    Objective To analyze the detection status and epidemiological characteristics of immunoglobulin M (IgM) antibodies of suspected measles and rubella cases in Hebei province from 2020 to 2024, thus providing technical support for optimizing the prevention and control strategies.
    Methods Enzyme-linked immunosorbent assay (ELISA) was employed to detect IgM antibodies in the serum samples of suspected measles and rubella cases in Hebei province from January 1, 2020 to December 31, 2024, and the test results were analyzed.
    Results A total of 8 064 serum samples were tested. Among them, 214 (2.65%) were positive for measles IgM antibodies, and 80 (0.99%) were positive for rubella IgM antibodies. The years 2020, 2021, 2022, 2023, and 2024 showed the annual positive rates of measles IgM antibodies being 5.38%, 2.70%, 2.05%, 1.89%, and 1.58% and the annual positive rates of rubella IgM antibodies being 2.30%, 0.97%, 0.85%, 0.54%, and 0.47%, respectively. The IgM antibody positive rates of both measles and rubella showed a declining trend from 2020 to 2024 (all P < 0.001). From 2020 to 2024, positive cases of both measles and rubella were detected among the suspected cases every month. The highest monthly positive rates for both measles (18.67%) and rubella (12.03%) occurred in January. Geographically, Cangzhou city had the highest measles IgM positive rate (4.73%), while Qinhuangdao city had the highest rubella IgM positive rate (4.21%). No significant gender difference (P > 0.05) was observed in the IgM antibody positive rate for measles (2.75% in males vs. 2.54% in females) or rubella (1.11% in males vs. 0.86% in females). Age-specific analysis revealed significant variations (P < 0.001). Specifically, the age groups of < 8 months, 8 months to 4 years, 5 to 9 years, 10 to 19 years, and ≥ 20 years showed the IgM antibody positive rates of measles being 3.77%, 3.95%, 1.45%, 1.99%, and 1.40% and the IgM antibody positive rates of rubella being 0.94%, 0.70%, 0.65%, 4.47%, and 0.75%, respectively. The IgM antibody positive rates of measles in suspected cases with no vaccination, one-dose vaccination, and two-dose vaccination were 2.80%, 8.46%, and 0.79%, respectively, showing significant differences (χ2 = 209.186, P < 0.001). The IgM antibody positive rates of rubella in suspected cases with no vaccination, one-dose vaccination, and two-dose vaccination were 1.16%, 1.34%, and 0.76%, respectively, showing no significant difference (P > 0.05).
    Conclusions The IgM antibody positive rates of measles and rubella in suspected cases in Hebei province consistently declined from 2020 to 2024, being the highest in January. Cangzhou and Qinhuangdao were identified as key areas for the prevention and control of measles and rubella, respectively. Measles prevention should prioritize younger age groups and individuals who have not completed the full vaccination course, whereas rubella prevention efforts should focus on the population of 10 - 19 years old.

     

/

返回文章
返回